Koen W . Streng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Plasma concentrations of natriuretic peptides decline with obesity in patients with heart failure. Whether this is true for other biomarkers is unknown. We investigated a wide range of biomarker profiles in acute heart failure across the body mass index (BMI) spectrum. METHODS AND RESULTS A total of 48 biomarkers, assessing multiple(More)
BACKGROUND Renin-angiotensin aldosterone system (RAAS) inhibitors significantly improve outcome in heart failure (HF) patients with reduced ejection fraction (HFREF), irrespective of the occurrence of worsening renal function (WRF). However, in HF patients with preserved ejection fraction (HFPEF), RAAS inhibitors have not been shown to improve outcome but(More)
In the past 3 decades, the introduction of renin–angiotensin aldosterone system (RAAS) inhibitors has significantly improved morbidity and mortality in chronic heart failure (HF) patients with reduced ejection fraction (HFREF). Although RAAS inhibitors have beneficial effects on the heart and vasculature, they also induce a small decrease in renal function(More)
  • 1